Did you know there is up to a one in four chance that you could be infected with tuberculosis (TB) bacteria?
Fortunately, only a fraction of those infected develop active TB, but for individuals co-infected with HIV, the risk increases 20 to 30 times.
TB spreads through the air when an infected person coughs, sneezes, speaks, or sings, releasing bacteria that others inhale.
Active TB remains a leading cause of death, particularly affecting adults in their most productive years.
According to the World Health Organization (WHO), over one million people lost their lives to TB last year, and this number is expected to rise as global health funding declines, jeopardizing treatment programs.
The good news is that TB is curable, and early diagnosis can significantly reduce its impact.
However, Africa faces a major challenge—despite notable progress in TB control over the past two decades, funding cuts are disrupting essential services.
These setbacks have led the WHO to call on governments, healthcare providers, civil society, and the private sector to strengthen collaboration in expanding TB prevention, diagnosis, and treatment.
Underfunding, especially in diagnostics, remains a critical issue. Without early testing, TB continues to spread, leading to higher treatment costs, more hospitalizations, and increased fatalities.
Investment in diagnostic services has demonstrated remarkable returns. A South African study (2013-2022) found that investing in TB diagnostics yielded significant health and economic benefits.
TB testing had a Return on Investment (ROI) of 19.0, meaning every $1 invested generated $19 in benefits. Other diagnostic programs, such as HIV viral load testing (ROI 1.4), early infant HIV diagnosis (ROI 64.8), and SARS-CoV-2 testing (ROI 2.5), also showed positive impacts.
These findings highlight the economic and public health value of prioritizing diagnostics in national healthcare systems.Africa’s healthcare has historically relied on external donors, but global priorities are shifting.
It is time for the continent to take charge of its healthcare funding. Strong economies invest in their health, and nations that integrate comprehensive diagnostics into national budgets reduce long-term healthcare costs. Smart allocation of limited domestic resources can transform healthcare systems, ensuring sustainability and self-reliance.
Many African countries already have diagnostic platforms designed for HIV testing, yet TB and other diseases are often tested separately. This leads to duplication of resources, increased costs, and inefficiencies.
The WHO advocates for integrated diagnostics, where a single platform can test for multiple diseases, improving efficiency and cutting costs.
By forging strategic partnerships, governments can expand diagnostic capacity, integrate cost-effective innovations, and train healthcare professionals to deliver faster, more accurate care.
TB has been part of Africa’s health challenges for far too long, but this story is not unchangeable.
The tools to combat TB already exist—early diagnosis, improved testing infrastructure, and strategic healthcare investments.
The real question is not whether Africa can overcome TB, but whether it will take decisive action.
A future where Africa funds its own healthcare, prioritizes early diagnostics, and builds resilient health systems is within reach.
The path forward is clear—it simply requires political will and commitment. The time for action is now. A healthier, self-reliant Africa is possible!




